BackgroundCheck.run
Search For

Jeremy R Chien, 534951 Wrangler Ct, Folsom, CA 95630

Jeremy Chien Phones & Addresses

Folsom, CA   

Elk Grove, CA   

2408 59Th St NW, Rochester, MN 55901    507-2881992   

Albuquerque, NM   

Shawnee Mission, KS   

Overland Park, KS   

Lawrence, KS   

Kansas City, KS   

Pittsburg, KS   

Amarillo, TX   

Social networks

Jeremy R Chien

Linkedin

Work

Company: University of kansas medical center Apr 2012 Position: Assistant director of translational genomics

Education

Degree: Post-doctoral fellow School / High School: Mayo Clinic College of Medicine 2001 to 2006 Specialities: Tumor Biology

Interests

Ovarian Cancer, Chemotherapeutics, Novel Therapeutics, Genomics, Cancer Biology,

Industries

Research

Mentions for Jeremy R Chien

Jeremy Chien resumes & CV records

Resumes

Jeremy Chien Photo 25

Assistant Director Of Translational Genomics

Position:
Assistant Director of Translational Genomics at University of Kansas Medical Center
Location:
Kansas City, Kansas
Industry:
Research
Work:
University of Kansas Medical Center since Apr 2012
Assistant Director of Translational Genomics
Mayo Clinic Apr 2006 - Apr 2012
Assistant Professor
Education:
Mayo Clinic College of Medicine 2001 - 2006
Post-doctoral fellow, Tumor Biology
University of Kansas Medical Center 1994 - 2000
Doctor of Philosophy (Ph.D.), Physiology, General
Pittsburg State University 1991 - 1994
Bachelor's degree, Biology, General
Interests:
Ovarian Cancer, Chemotherapeutics, Novel Therapeutics, Genomics, Cancer Biology,

Publications & IP owners

Us Patents

Treating Pre-Eclempsia And Cardiovascular Diseases

US Patent:
2010019, Aug 5, 2010
Filed:
Mar 12, 2008
Appl. No.:
12/530917
Inventors:
Vijayalakshmi Shridhar - Rochester MN, US
Jeremy R. Chien - Rochester MN, US
Brian C. Brost - Rochester MN, US
Funminiyi A. Ajayi - Rochester MN, US
Assignee:
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH - Rochester MN
International Classification:
G01N 33/53
G01N 33/00
US Classification:
435 792, 436 86
Abstract:
This document relates to methods and materials involved in identifying, predicting, and treating pre-eclampsia or a cardiovascular disease (e.g., atherosclerosis) in mammals. For example, methods and materials involved in using serum levels of HtrA polypeptides to identify pre-eclampsia or a cardiovascular disease, using HTRA polymorphisms to predict pre-eclampsia or a cardiovascular disease, and using HtrA antibodies to treat pre-eclampsia or a cardiovascular disease in mammals (e.g., humans) are provided.

Bex4 Nucleic Acids, Polypeptides, And Method Of Using

US Patent:
2007000, Jan 4, 2007
Filed:
Feb 12, 2004
Appl. No.:
10/543859
Inventors:
Viji Shridhar - Rochester MN, US
Jeremy Chien - Rochester MN, US
International Classification:
A61K 48/00
A61K 38/54
C12Q 1/68
G01N 33/574
C12N 15/09
US Classification:
514012000, 514044000, 435006000, 435007230, 435320100
Abstract:
Bex4 nucleic acids and polypeptides are provided, as are methods of using the nucleic acids and polypeptides.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.